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An outbreak of infections affecting 311 patients who had undergone different invasive procedures occurred in 2004
and 2005 in the city of Bele´m, in the northern region of Brazil. Sixty-seven isolates were studied; 58 were from
patients who had undergone laparoscopic surgeries, 1 was from a patient with a postinjection abscess, and 8 were
from patients who had undergone mesotherapy. All isolates were rapidly growing nonpigmented mycobacteria and
presented a pattern by PCR-restriction enzyme analysis of the hsp65 gene with BstEII of bands of 235 and 210 bp
and with HaeIII of bands of 200, 70, 60, and 50 bp, which is common to Mycobacterium abscessus type 2, Mycobac-
terium bolletii, and Mycobacterium massiliense. hsp65 and rpoB gene sequencing of a subset of 20 isolates was used to
discriminate between these three species. hsp65 and rpoB sequences chosen at random from 11 of the 58 isolates
from surgical patients and the postinjection abscess isolate presented the highest degrees of similarity with the
corresponding sequences of M. massiliense. In the same way, the eight mesotherapy isolates were identified as M.
bolletii. Molecular typing by pulsed-field gel electrophoresis (PFGE) grouped all 58 surgical isolates, while the
mesotherapy isolates presented three different PFGE patterns and the postinjection abscess isolate showed a unique
PFGE pattern. In conclusion, molecular techniques for identification and typing were essential for the discrimi-
nation of two concomitant outbreaks and one case, the postinjection abscess, not related to either outbreak, all of
which were originally attributed to a single strain of M. abscessus.
Rapidly growing mycobacteria (RGM) are widely distrib-
uted in the environment, especially in water (rivers, lakes,
potable water), and can contaminate reagents and medical
equipment. Most RGM infections in humans are caused by
species belonging to the Mycobacterium fortuitum, Mycobacte-
rium chelonae-Mycobacterium abscessus, and Mycobacterium
smegmatis groups (6).
The M. chelonae-M. abscessus group comprises two genomo-
species, M. chelonae and M. abscessus, which have been differ-
entiated on the basis of 70% genomic homology by DNA-
DNA hybridization (16, 18). These species have been isolated
from sporadic cases of chronic lung disease associated with
bronchiectasis and cystic fibrosis, disseminated cutaneous in-
fections, and postsurgical wound infections. They have also
been implicated in outbreaks in cardiac, ophthalmologic, and
plastic surgeries and pseudo-outbreaks related to contami-
nated bronchoscopes and contaminated laboratory reagents (6,
12, 20, 25, 26). Mycobacterium immunogenum was included in
this group in 2001. It was isolated from metalworking fluids
and was associated with cases of hypersensitivity pneumonitis
in factory workers. This species has also been detected in
cutaneous, catheter-related, articular, and lung infections; in
an outbreak related to ophthalmologic surgeries; and in a
pseudo-outbreak related to bronchoalveolar lavage procedures
(19, 27). Mycobacterium massiliense was validated as a species
separate from the M. chelonae-M. abscessus group in 2006 (11).
It has been isolated from pulmonary specimens, from a pace-
maker pocket infection, and during an outbreak associated
with intramuscular injections (4, 15, 22). Mycobacterium bolletii
has been isolated from 4 of 59 specimens from a collection of
clinical RGM isolates and was recognized as a species separate
from the M. chelonae-M. abscessus group in 2006 (1).
The discrimination of species belonging to this group is
important for epidemiological studies, the prediction of anti-
biotic susceptibility, and the recognition of medically impor-
tant taxa. Few phenotypic tests can distinguish RGM species,
and the discriminatory power of lipid analysis by high-perfor-
mance liquid chromatography is limited due to profile similar-
ities (5). Individual species of the M. chelonae-M. abscessus
group present differences in their antimicrobial susceptibilities.
The most pronounced differences between M. abscessus and M.
chelonae are in their susceptibilities to cefoxitin (with M.
abscessus being generally susceptible and M. chelonae being
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resistant) and tobramycin (with M. abscessus being resistant
and M. chelonae being susceptible) (6). M. immunogenum is
resistant to both drugs (27). It was reported that M. massiliense
could be distinguished by its susceptibility to doxycycline, while
other members of this group are resistant to this drug (4). M.
massiliense isolates with intermediate susceptibility to doxycy-
cline were also identified (15). M. bolletii was described as a
species highly resistant to antimicrobial drugs, including cla-
rithromycin, to which the other members of the group are
highly susceptible (1). Five different patterns have been ob-
served by PCR-restriction enzyme analysis of the hsp65 gene
(PRA-hsp65) among species belonging to the M. chelonae-M.
abscessus group: M. chelonae type 1, M. abscessus type 1 and
type 2, and M. immunogenum type 1 and type 2, respectively (8,
19, 27). M. massiliense and M. bolletii present an indistinguish-
able PRA-hsp65 pattern, described as M. abscessus type 2,
precluding the separation of these species by this method. By
16S rRNA sequencing, M. chelonae and M. abscessus differ by
only 4 bp and have identical 16S rRNA hypervariable region A
sequences; M. immunogenum differs by 8 bp from M. abscessus
and by 10 bp from M. chelonae; M. massiliense and M. bolletii
show 100% sequence similarity with M. abscessus. Therefore,
16S rRNA sequencing is not adequate for the discrimination of
these species. Differentiation is best achieved by analysis of
polymorphisms either in the rpoB, hsp65, sodA, and recA genes
or in the 16S-23S rRNA internal transcribed sequence (2, 3, 9).
This report describes the molecular identification and typing
of isolates obtained during an outbreak of infections after
invasive procedures in Bele´m, Brazil. To our knowledge, this is
the first report of infections caused by the recently described
species M. massiliense and M. bolletii in Brazil.
MATERIALS AND METHODS
Mycobacterial isolates. From February 2004 to June 2005, 311 patients who
had undergone different invasive procedures, performed in 16 private hospitals
and clinics in the city of Bele´m, state of Para´, in the northern region of Brazil,
presented with signs and symptoms of localized infection. One-hundred seventy
specimens were collected at the Instituto Evandro Chagas by needle aspiration of
secretions, by surgical biopsy, or from the open drainages of abscesses and were
cultivated at 37°C on Lo¨wenstein-Jensen solid medium for up to 4 weeks. Sixty-
seven isolates were included in this study. Fifty-eight isolates were obtained from
patients who had undergone surgery; eight were from patients who had under-
gone mesotherapy, a procedure comprising multiple subcutaneous injections of
pharmaceutical and/or homeopathic medications for cosmetic purposes; and one
was from an abscess after the intramuscular injection of a contraceptive.
Species identification. All isolates were identified by analysis of their charac-
teristics on culture (the time for growth and pigment production) and by PRA-
hsp65. In brief, a 441-bp fragment of the hsp65 gene, Telenti’s fragment, was
amplified with primers Tb11 (ACCAACGATGGTGTGTCCAT) and Tb12 (C
TTGTCGAACCGCATACCCT), as described before (17, 23). The PCR mixture
was used as a negative control. The amplicons were digested with BstEII (Pro-
mega) and HaeIII (Invitrogen), and the restriction fragments were separated by
electrophoresis in 3% Seakem LE (BioWhittaker Molecular Applications) aga-
rose gels stained with ethidium bromide. Fifty- and 25-bp DNA ladders (Invitro-
gen) were used as molecular standards.
As the PRA-hsp65 pattern obtained was common to the three different spe-
cies, a subset of isolates was submitted to DNA sequencing to discriminate
between these species. Two DNA targets were sequenced: a 667-bp fragment of
the hsp65 gene containing Telenti’s fragment was amplified with primers
hsp667forward (GGCCAAGACAATTGCGTACG) and hsp667-reverse (GGA
GCTGACCAGCAGGATG) (21), and a 752-bp fragment of rpoB region V was
amplified with primers MycoF (GGCAAGGTCACCCCGAAGGG) and MycoR
(AGCGGCTGCTGGGTGATCATC) (2). The PCR mixture was used as nega-
tive control. To obtain consensus hsp65 and rpoB sequences, the amplicons from
isolate B5, chosen at random from among the 58 isolates from surgical patients,
were cloned before sequencing by using the TOPO TA cloning kit for sequencing
(Invitrogen), according to the manufacturer’s recommendations. Recombinant
plasmids were purified from the isolated colonies with the Wizard Plus SV
Minipreps DNA purification system (Promega) and were sequenced with BigDye
Terminator cycle sequencing reagents and primers M13F and M13R (Invitro-
gen). Cycle sequencing was performed with a Perkin-Elmer 9600 GeneAmp PCR
system programmed for 25 cycles at 96°C for 20 s, 50°C for 10 s, and 60°C for 4
min. The sequencing products were cleaned with CentriSep spin columns, ac-
cording to the manufacturer’s instructions (Princeton Separations, Applied Bio-
systems), and were then analyzed on a ABI Prism 3100 sequencer (Perkin-Elmer,
Applied Biosystems).
The sequences were assembled from the ABI chromatograms by using the
PHRED, PHRAP, and CONSED programs (13). The quality of the assembled
sequences (the phred scores) ranged from 0 to 1.45 per 10 kb, as estimated with
the CONSED program. Consensus sequences corresponding to 401 bp of the
hsp65 gene (the 441-bp Telenti’s fragment without the sequences of the primers
at both ends) and to 711 bp of the rpoB gene (752 bp from rpoB region V without
the sequences of the primers at both ends) were identified by similarity analysis
with the sequences in the GenBank database by use of the BLAST program
(Basic Local Alignment Search Tool; http://www.ncbi.nlm.nih.gov/BLAST).
The hsp65 and rpoB amplicons of 19 additional isolates were submitted to
direct sequencing: 10 isolates (isolates B51, B49, B37, B31, B25, B58, B52, B43,
B50, and B30) randomly chosen from among the 58 available isolates from
surgical patients operated on in different hospitals, 8 isolates from mesotherapy
patients (isolates B59 to B66), and 1 isolate (isolate B67) from the postinjection
abscess. As these sequences were obtained from noncloned PCR products, the
data output from the sequencer had to be processed, and a pipeline was devel-
oped for this purpose by using the Egene platform (10). The trace files were
initially submitted to analysis with the PHRED program for base calling and
quality assessment. Then, the primers sequences were masked by use of the
cross_match program (P. Green, 1997, http://www.phrap.org/phredphrapconsed
.html). After masking of the primer sequences, a trimming process was per-
formed to eliminate masked and low-quality (phred value, 15) regions from the
3 and the 5 ends of the sequence. The surviving sequences were subjected to a
size filter (minimum sizes, 350 bp for hsp65 and 670 bp for rpoB). Next, the
resulting sequences with less than 90% of the bases with phred values above 15
across the minimum size were filtered. These sequences were aligned by using
the BioEdit program (version 7.0.5.3) (14) and the CLUSTALW algorithm.
Molecular typing. Pulsed-field gel electrophoresis (PFGE) was performed as
described by Coleman and Spain (7), with modifications. Colonies were culti-
vated in 30 ml of Mueller-Hinton broth supplemented with 0.1% Tween 80 at
37°C on a rotatory shaker until an optical density of 0.64 at 650 nm was achieved.
The cells were pelleted and frozen at 80°C for 1 h. After they were thawed, the
cell pellets were resuspended in a solution of 100 mM NaCl, 10 mM Tris, pH 8.0,
50 mM EDTA, and 0.1% Tween 80. The suspension was mixed with an equal
volume of 1% low-melting-point preparative-grade agarose (Bio-Rad Laborato-
ries) in 125 mM EDTA prewarmed to 55°C, and the mixture was cast into plug
molds. The plugs were treated with 2 ml of 10 mg/ml lysozyme in a solution of
100 mM NaCl, 10 mM Tris, pH 8.0, and 50 mM EDTA at 37°C overnight and
were then incubated at 4°C for 1 h in 0.5 M EDTA plus 1% Sarkosyl. Proteinase
K (BioAmerica, Brazil) was added at a final concentration of 2 mg/ml, and the
plugs were incubated at 55°C for 24 h and then at 4°C for 1 h. The plugs were
washed with 1 Tris-EDTA (TE) and incubated in 1 TE containing 0.12 mg/ml
phenylmethylsulfonyl fluoride (Sigma) for 1 h at 55°C. The plugs were washed
once in 1 TE and once in 0.1% Triton for 90 min and digested with 30 U of
DraI (Promega) at 37°C overnight or were stored in 0.5 M EDTA at 4°C until
they were used. After digestion, the plugs were washed in 0.05 M EDTA, loaded
into 1% pulsed-field-certified agarose gels (Bio-Rad) prepared in 0.5 TBE
buffer (45 mM Tris-HCl, 45 mM boric acid, 1 mM EDTA), and subjected to
electrophoresis in 0.5 TBE buffer. PFGE was carried out in a CHEF-DR III
system (Bio-Rad) at 14°C for 24 h at 6 V/cm, with a switch time of 1.6 to 21.3 s.
A bacteriophage lambda ladder PFG marker (New England BioLabs) was used
as a molecular standard.
The PFGE gel images were analyzed with the BioNumerics program (version
4.5; AppliedMaths, Sint-Martens-Latem, Belgium). The PFGE patterns of type
strains M. abscessus ATCC 19977 and M. chelonae ATCC 35752 were included in
the analysis. The band-based Dice unweighted pair group method with arith-
metic mean method was used to prepare dendrograms of the PFGE profiles,
based on 2% optimization and position tolerance. The PFGE interpretative
criteria were those described by Tenover et al. (24).
Nucleotide sequence accession numbers. The consensus sequences obtained
from isolate B5 were deposited in GenBank under accession numbers EU117205
(hsp65) and EU117207 (rpoB). The hsp65 and rpoB gene sequences from isolates
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B67, B60, B62, and B66, which represented all sequevars detected in this work,
were deposited in GenBank under accession numbers EU220417 to EU220424.
RESULTS
Outbreak description. From February 2004 to June 2005,
311 patients who underwent different types of surgeries involv-
ing the use of laparoscopes or cannulas or other invasive pro-
cedures, such as mesotherapy and intramuscular injection (Ta-
ble 1), presented with signs and symptoms of localized
infection. The clinical manifestations included local hyper-
emia; vesicles; abscess formation with either an acute inflam-
matory reaction and festering or a chronic evolution; nodules;
ulceration at the portal of entry of laparoscopes; fistulization
with serous, bloody, or purulent secretions; difficulty in cica-
trization; low fever; and a lack of a response to conventional
treatment for common skin bacterial pathogens. Generalized
infections or deaths were not reported.
All surgeries were performed in 16 private hospitals in the
city of Bele´m and mesotherapy was performed in one private
clinic in Bele´m. Sixty-seven percent of the cases were concen-
trated in three hospitals, and in 17 cases, the institutions where
the procedures were performed were not reported. One pa-
tient received a contraceptive injection in a different city and
developed a local abscess, which was initially attributed to a
Proteus sp. Treatment for this abscess, including antibiotics and
surgical debridement, was performed in Bele´m, and an addi-
tional specimen yielded a positive culture for RGM.
A total of 225 (72.35%) patients were female and 86
(27.65%) were male, and for 1 (0.31%) patient this informa-
tion was unknown. The patients’ ages ranged from 10 to 89
years (mean, 45 years; standard deviation, 13.87 years).
Identification results. Sixty-seven isolates, which were ob-
tained at the Instituto Evandro Chagas, were identified as
rapidly growing nonpigmented mycobacteria and presented a
pattern by PRA-hsp65 with BstEII with bands of 235 of 210 bp
and with HaeIII with bands of 200, 70, 60, and 50 bp, which is
common to M. abscessus type 2, M. bolletii, and M. massiliense.
To discriminate between these three species, a subset of 20
isolates, including 11 isolates chosen at random from among
the 58 isolates from surgical patients, all 8 isolates from me-
sotherapy patients, and the single isolate from the postinjec-
tion abscess, was submitted to DNA sequencing of the hsp65
and rpoB genes. Consensus hsp65 and rpoB sequences were
initially obtained by cloning the amplicons from isolate B5,
which was chosen at random for this purpose. BLASTn anal-
ysis of the hsp65 and rpoB consensus sequences showed the
highest indexes of similarity with the corresponding sequences
from M. massiliense (GenBank accession numbers AY596465
and AY593981) and M. bolletii (GenBank accession numbers
AY859675 and AY859692) (Table 2).
The other sequences were obtained by direct sequencing of
the PCR products. CLUSTALW analysis of the hsp65 se-
quences revealed that the sequences from the surgical isolates
and the postinjection abscess isolate presented 100% similarity
to the sequence of M. massiliense CIP 108297 deposited in the
GenBank database and differed from the sequence of M.
bolletii CIP 108541 at three positions (99.25% similarity). Six of
the eight sequences from the mesotherapy isolates were
100% similar to the sequence from the M. bolletii type strain
(GenBank accession number AY859675); two isolates (isolates
B59 and B60) presented a single substitution at position 253
(99.75% similarity).
The rpoB sequences from the surgical isolates analyzed were
identical. Their sequences presented five mismatches com-
pared to the sequence of M. massiliense type strain CIP 108297
deposited in the GenBank database (99.29% similarity) and 11
mismatches compared to the sequence of M. bolletii CIP
TABLE 1. Type of surgery or invasive procedure performed for
patients from this study
Procedure No. of patients % of all patients
Cholecystectomy 182 58.52
Hiatal hernia 22 7.07
Diagnostic laparoscopy 15 4.82
Bariatric surgery 11 3.54
Other surgical proceduresa 42 13.5
Mesotherapy 14 4.5
NRb 25 8.04
Total 311 100
a Other surgical procedures included mammaplasty, liposuction, ooforectomy,
miomectomy, appendectomy, salpingectomy, cystectomy, and kidney stone ex-
traction.
b NR, not reported.
TABLE 2. BLASTn analysis of the consensus hsp65 (401 bp) and rpoB (711 bp) sequences from isolate B5
Gene region GenBankaccession no. Strain
No. of identical
nucleotides/
total no.
Index of
similarity (%)
to isolate B5
hsp65 AY596465 M. massiliense CIP 108297 401/401 100
AY859675 M. bolletii CIP 108541 398/401 99.25
AY458075 M. abscessus CIP 104536 396/401 98.75
AY458074 M. chelonae CIP 104535 371/401 92.5
DQ288262 M. immunogenum F1112 370/401 92.26
AY458081 M. immunogenum CIP 106684 367/401 91.52
rpoB AY593981 M. massiliense CIP 108297 706/711 99.29
AY859692 M. bolletii CIP 108541 700/711 98.45
DQ288264 M. immunogenum F1112 633/651 97.23
AY262739 M. immunogenum CIP 106684 691/711 97.18
AY147164 M. abscessus CIP 104536 686/711 96.48
AY147163 M. chelonae CIP 104535 679/711 95.49
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108541 (98.45% similarity). The rpoB sequence of the postin-
jection abscess isolate presented 99.1% similarity with the se-
quence of M. massiliense CIP 108297 and 98% similarity with
that of M. bolletii CIP 108541. It also differed from the rpoB
sequence of the surgical isolates at five positions (99.25% sim-
ilarity).
The mesotherapy isolates comprised three rpoB sequevars.
The rpoB sequences from two isolates (isolates B59 and B60)
presented 100% similarity to the corresponding sequence of M.
bolletii CIP 108541 and 98% similarity to the sequence of
M. massiliense CIP 108297. Compared to the rpoB sequence
of M. bolletii CIP 108541, the rpoB sequences of three isolates
(isolates B61, B62, and B65) had two substitutions (99.56%
similarity) and those of the remaining isolates (isolates B63,
B64, and B66) had one substitution (99.85% similarity). Com-
pared to the rpoB sequence of M. massiliense CIP 108297, these
two sequevars presented 97.66% and 97.93% similarities, re-
spectively.
In conclusion, the isolates from the surgical patients and
from the postinjection abscess were identified by the highest
similarity of sequences as M. massiliense, while the meso-
therapy isolates were classified as M. bolletii.
Molecular typing results. All isolates generated interpret-
able patterns by PFGE. Except for eight isolates that lacked
one band, the isolates from surgical patients presented indis-
tinguishable patterns (Fig. 1). According to the criteria pro-
posed by Tenover et al. (24), these isolates were considered
highly related and to belong to the same strain. The M. mas-
siliense isolate from the postinjection abscess presented a
clearly distinct PFGE pattern, showing 46.7% similarity with
the patterns from the surgical isolates.
The mesotherapy isolates were distributed in three clusters,
each of which showed indistinguishable PFGE patterns. The
clusters comprised four isolates (isolates B63 to B66), two
isolates (isolates B59 and B60), and two isolates (isolates B61
and B62), respectively. These PFGE patterns differed from the
patterns of the surgical isolates and the postinjection abscess
isolate (Fig. 1). The overall similarity of the PFGE patterns of
the mesotherapy isolates was 68.7%.
DISCUSSION
From 1999 to 2003, between 4 and 12 nontuberculous my-
cobacterial infections were diagnosed each year at the Myco-
bacteria Laboratory of the Instituto Evandro Chagas in Bele´m,
Brazil, and no more than one isolate per year presented the
PRA-hsp65 pattern reported here. Most isolates were obtained
from respiratory specimens. Unexpectedly, from October 2004
on, several isolates that presented this PRA-hsp65 pattern
were isolated from specimens from patients who had under-
gone invasive procedures. An epidemiological investigation
was initiated, and in parallel, the isolates were identified and
typed by the use of molecular methods.
This PRA-hsp65 pattern was initially described as character-
istic of that of M. abscessus (8) and was later observed in two
recently described species from the M. chelonae-M. abscessus
group, M. massiliense and M. bolletii (1, 4). Discrimination of
these closely related species is best achieved by DNA sequenc-
ing. By consideration of the 401-bp fragment from the hsp65
gene, the sequences of M. massiliense (GenBank accession
number AY596465) and M. bolletii (GenBank accession num-
ber AY859675) differ at three nucleotides (99.25% similarity);
however, this polymorphism does not affect the PRA-hsp65
pattern. Region V of the rpoB gene was shown to be more
polymorphic (1, 2). In general, the RGM interspecies sequence
divergence is 3%, and isolates presenting less than 1.7%
sequence divergence are considered to belong to the same
species (2). M. massiliense CIP 108297 and M. bolletii CIP
108541 have 98% similarity in the rpoB region V sequences
and are presently considered to be two separate species.
As the differentiation of these species by hsp65 and rpoB
sequencing relies on few polymorphisms, the quality of the
sequences obtained is of utmost importance. For this reason, a
strategy was devised in which one isolate (isolate B5), chosen
from among the 58 isolates from surgical patients which pre-
sented indistinguishable PFGE patterns, had hsp65 and rpoB
amplicons cloned to obtain reliable consensus sequences. The
highest similarities of the consensus sequences of isolate B5
were observed with the respective sequences of M. massiliense
(Table 2). The hsp65 and rpoB sequences of 10 additional
isolates from surgical patients, obtained by direct sequencing
of the PCR products, were indistinguishable from the hsp65
and rpoB sequences of isolate B5.
It is important to point out that even though the highest
sequence similarity for rpoB (99.29%) was observed with the
corresponding sequence from M. massiliense, the similarity to
the rpoB sequence from M. bolletii was also high (98.45%),
corresponding to divergences of 1.7% in both cases. Accord-
ing to the criteria proposed by Adekambi et al. (2), these
isolates could be identified as either M. massiliense or M.
bolletii. The rpoB sequences from surgical isolates showed
100% similarity to two recently deposited rpoB sequences
(GenBank accession numbers EU090065 and EU090066) from
isolates identified as M. massiliense in a recent publication (22).
Taking all of this into account, M. massiliense was considered
the conclusive identification for the isolates from the surgical
patients described here.
The hsp65 and rpoB sequences of the postinjection abscess
isolate also showed the highest similarities to the correspond-
ing sequences of M. massiliense. Compared to the sequences of
the surgical isolates, the hsp65 sequence of the postinjection
abscess isolate was identical and the rpoB sequence of the
postinjection abscess isolate presented five mismatches, sug-
gesting that this isolate belonged to a different strain of M.
massiliense and indicating that this patient was not epidemio-
logically related to the surgical cases. Molecular typing results
confirmed that this isolate presented a distinct PFGE pattern,
strongly suggesting that this abscess represented an isolated
infection not related to the outbreak.
M. massiliense was reported to be susceptible to doxycycline,
which could distinguish it from resistant M. abscessus and M.
bolletii isolates (4). M. massiliense isolates with intermediate
susceptibility to doxycycline have also been described (15). In
the present study, nine M. massiliense isolates from surgical
patients (isolates B51, B41, B31, B5, B22, B28, B43, B48, and
B19) were shown to be resistant to doxycycline (MICs  64
g/ml) (data not shown) These results agree with those re-
ported by Simmon et al. (22), indicating that this species does
not have a unique pattern of susceptibility to this drug. More-
over, the doxycycline resistance and the identity of the rpoB
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region V sequences of Brazilian and U.S. isolates (22) could
suggest the existence of a variant clone of M. massiliense in the
Americas.
A different result was obtained with isolates from meso-
therapy patients. The hsp65 and rpoB sequences presented the
highest similarities with the corresponding sequences from M.
bolletii CIP 108541, and this is probably the correct identifica-
tion for these isolates. Isolates from mesotherapy patients also
presented three distinct PFGE patterns that were clearly sep-
arated from the patterns observed for the surgical isolates.
Therefore, even though the mesotherapy infections were con-
comitant with the surgical cases, they are most likely unrelated
FIG. 1. Dendrogram of PFGE patterns of isolates from this study. Indistinguishable patterns grouped the isolates from surgical patients;
however, the patterns of eight isolates lacked one restriction band. Three clusters of indistinguishable patterns were detected in the mesotherapy
isolates, but none of the patterns matched the patterns of the surgical isolates. The columns on the right indicate the type of procedure, the
procedure date, and the isolate number. Comparison was performed with the BioNumerics (version 4.5) program and by analysis by the Dice
unweighted pair group method with arithmetic mean method, based on 2% optimization and position tolerance. The PFGE patterns of M.
abscessus ATCC 19977 and M. chelonae ATCC 35752 were included in the analysis.
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to the outbreak of laparoscopic surgeries and may have had
different sources.
The sources of the infections for the surgical cases have not
been identified here. The patients were operated on by differ-
ent surgeons, who used their own laparoscopic equipment,
which was disinfected by immersion in 2% glutaraldehyde be-
tween surgeries and which was used in different hospitals.
Glutaraldehyde, a frequently employed biocide, can be used
for the high-level disinfection of some medical equipment after
careful cleaning for the elimination of organic substances.
Without adequate cleaning, surgical or medical equipment can
accumulate organic material, generating biofilms and prevent-
ing the action of disinfectants. Our hypothesis is that inconsis-
tencies in equipment cleaning, glutaraldehyde concentrations,
or contact times may have contributed to the selection of the
M. massiliense strain described here, which contaminated the
surgical equipment. The use of laparoscopic equipment in sev-
eral hospitals disseminated the strain to the different outbreak
settings. Cases of infection after laparoscopic surgeries subsided
after the cleaning and sterilization procedures were reviewed. No
RGM infections were reported in patients who underwent differ-
ent surgical procedures, in which laparoscopic equipment or can-
nulas and disinfection with glutaraldehyde were not employed,
during the same period and in the same hospitals.
The prevalence of this particular M. massiliense strain could
have originated from its atypical survival ability in different
environments, resistance to biocides, and/or enhanced biofilm
formation. It is also possible that this particular strain may be
unusually resistant to the disinfectant used, and experiments to
test this hypothesis are under way.
In conclusion, this outbreak, which was initially attributed to
M. abscessus, in fact consisted of two concomitant but different
outbreaks. The main outbreak grouped 298 surgical patients
who were operated on in several hospitals and was probably
caused by a single strain of M. massiliense. The other outbreak
clustered 14 mesotherapy patients who were treated in a pri-
vate clinic and involved multiple strains of M. bolletii. The
postinjection abscess case was not related to either outbreak.
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